Employment of a natural deep eutectic solvent as a sustainable mobile phase additive for improving the isolation of four crucial cardiovascular drugs by micellar liquid chromatography

Abstract

Modification of micellar liquid chromatography (MLC) with a natural deep eutectic solvent (NADES) and butanol was effectively performed for analysis of four crucial cardiovascular drugs namely aspirin, atorvastatin, metformin, and metoprolol. The multivariate software tools were employed for screening and optimizing the primary experimental parameters including sodium dodecyl sulphate concentration ([SDS]) as well as the volume percentages of NADES, butanol, and glacial acetic acid (GAC). By using the desirability function, the optimal framework of the mobile phase was obtained at volume ratio of 83:10:3.5:3.5, respectively, for SDS (0.09 mol L−1), butanol, NADES, and GAC. Moreover, the curvature and effect plots were applied for evaluating the robustness of the procedure. At the optimal conditions, the drugs were excellently separated within a total analysis time of 12 min when the flow rate of the mobile phase was 1 mL min−1. To certify the performance of the developed procedure, the Food and Drug Administration guidelines for bioanalytical analysis have been implemented. The designed MLC system was successfully utilized for the quantification of the drugs in urine and plasma samples.